Trial Identifier: | D0816C00016 |
Sponsor: | AstraZeneca |
NCTID:: | NCT03534453 |
Start Date: | May 2018 |
Primary Completion Date: | October 2023 |
Study Completion Date: | October 2023 |
Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
China | Beijing, China, 100142 |
China | Changsha, China, 410013 |
China | Chengdu, China, 610041 |
China | Chongqing, China, 400030 |
China | ChongQing, China, 400038 |
China | Hangzhou, China, 310006 |
China | Hangzhou, China, 310022 |
China | Harbin, China, 150081 |
China | Hefei, China, 230031 |
China | Jinan, China, 250012 |
China | shanghai, China, 200011 |
China | Shanghai, China, 200032 |
China | Shanghai, China, 200080 |
China | Shenyang, China, 110016 |
China | Tianjin, China |
China | Tianjin, China, 300060 |
China | Wuhan, China, 430079 |
China | Wuhan, China, CN-430030 |
China | Xian, China, 710061 |
China | Zhengzhou, China, 450008 |
India | Vellore, India, 632004 |
Malaysia | Johor Bahru, Malaysia, 81100 |
Malaysia | Kuala Lumpur, Malaysia, 59100 |
Malaysia | Kuala Lumpur, Malaysia |
Malaysia | Kuching, Malaysia, 93586 |
Malaysia | Putrajaya, Malaysia |